vs
Side-by-side financial comparison of Instil Bio, Inc. (TIL) and VirTra, Inc (VTSI). Click either name above to swap in a different company.
VirTra, Inc is the larger business by last-quarter revenue ($2.9M vs $2.2M, roughly 1.3× Instil Bio, Inc.). VirTra, Inc runs the higher net margin — -27.2% vs -365.3%, a 338.1% gap on every dollar of revenue. On growth, Instil Bio, Inc. posted the faster year-over-year revenue change (-19.2% vs -46.5%).
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
VirTra, Inc. is a global provider of highly realistic immersive training simulators and supporting curriculum, primarily serving law enforcement agencies, military units, and public safety organizations. Its scenario-based training systems are designed to enhance frontline personnel's decision-making, de-escalation skills, and on-duty operational safety.
TIL vs VTSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.2M | $2.9M |
| Net Profit | $-8.2M | $-792.4K |
| Gross Margin | — | 57.5% |
| Operating Margin | -426.3% | -47.9% |
| Net Margin | -365.3% | -27.2% |
| Revenue YoY | -19.2% | -46.5% |
| Net Profit YoY | 31.1% | 10.8% |
| EPS (diluted) | $-1.13 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2M | $2.9M | ||
| Q3 25 | $2.2M | $5.3M | ||
| Q2 25 | $2.2M | $7.0M | ||
| Q1 25 | $2.2M | $7.2M | ||
| Q4 24 | $2.8M | $5.4M | ||
| Q3 24 | $1.5M | $7.5M | ||
| Q2 24 | $0 | $6.1M | ||
| Q1 24 | $0 | $7.3M |
| Q4 25 | $-8.2M | $-792.4K | ||
| Q3 25 | $-13.6M | $-388.6K | ||
| Q2 25 | $-21.4M | $175.3K | ||
| Q1 25 | $-28.2M | $1.3M | ||
| Q4 24 | $-11.9M | $-888.3K | ||
| Q3 24 | $-23.0M | $583.1K | ||
| Q2 24 | $-14.9M | $1.2M | ||
| Q1 24 | $-24.3M | $468.2K |
| Q4 25 | — | 57.5% | ||
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | 69.0% | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 73.5% | ||
| Q2 24 | — | 90.9% | ||
| Q1 24 | — | 64.2% |
| Q4 25 | -426.3% | -47.9% | ||
| Q3 25 | -670.0% | -8.4% | ||
| Q2 25 | -1045.5% | 13.1% | ||
| Q1 25 | -1363.2% | 19.1% | ||
| Q4 24 | -426.1% | -9.9% | ||
| Q3 24 | -1582.8% | 10.1% | ||
| Q2 24 | — | 18.6% | ||
| Q1 24 | — | 8.9% |
| Q4 25 | -365.3% | -27.2% | ||
| Q3 25 | -606.0% | -7.3% | ||
| Q2 25 | -954.2% | 2.5% | ||
| Q1 25 | -1257.8% | 17.7% | ||
| Q4 24 | -428.8% | -16.3% | ||
| Q3 24 | -1541.9% | 7.8% | ||
| Q2 24 | — | 19.8% | ||
| Q1 24 | — | 6.4% |
| Q4 25 | $-1.13 | $-0.08 | ||
| Q3 25 | $-2.01 | $-0.03 | ||
| Q2 25 | $-3.24 | $0.02 | ||
| Q1 25 | $-4.32 | $0.11 | ||
| Q4 24 | $-1.82 | $-0.08 | ||
| Q3 24 | $-3.54 | $0.05 | ||
| Q2 24 | $-2.29 | $0.11 | ||
| Q1 24 | $-3.74 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.6M | $18.6M |
| Total DebtLower is stronger | — | $7.5M |
| Stockholders' EquityBook value | $113.9M | $45.6M |
| Total Assets | $203.5M | $65.1M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.6M | $18.6M | ||
| Q3 25 | $5.8M | $20.8M | ||
| Q2 25 | $7.7M | $20.7M | ||
| Q1 25 | $15.4M | $17.6M | ||
| Q4 24 | $8.8M | $18.0M | ||
| Q3 24 | $6.7M | $19.7M | ||
| Q2 24 | $6.8M | $18.4M | ||
| Q1 24 | $5.5M | $22.4M |
| Q4 25 | — | $7.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $113.9M | $45.6M | ||
| Q3 25 | $120.4M | $46.3M | ||
| Q2 25 | $131.7M | $46.8M | ||
| Q1 25 | $144.9M | $46.5M | ||
| Q4 24 | $169.4M | $45.2M | ||
| Q3 24 | $176.3M | $45.7M | ||
| Q2 24 | $195.0M | $44.9M | ||
| Q1 24 | $205.8M | $43.5M |
| Q4 25 | $203.5M | $65.1M | ||
| Q3 25 | $211.8M | $66.2M | ||
| Q2 25 | $231.0M | $67.4M | ||
| Q1 25 | $237.4M | $66.8M | ||
| Q4 24 | $263.6M | $65.0M | ||
| Q3 24 | $272.6M | $66.1M | ||
| Q2 24 | $294.3M | $66.0M | ||
| Q1 24 | $306.3M | $69.4M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.17× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.1M | $-1.5M |
| Free Cash FlowOCF − Capex | — | $-2.1M |
| FCF MarginFCF / Revenue | — | -72.5% |
| Capex IntensityCapex / Revenue | — | 21.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.1M | $-1.5M | ||
| Q3 25 | $-10.6M | $36.3K | ||
| Q2 25 | $-14.8M | $6.0M | ||
| Q1 25 | $-4.2M | $65.7K | ||
| Q4 24 | $-10.6M | $-908.7K | ||
| Q3 24 | $-20.1M | $897.7K | ||
| Q2 24 | $-10.6M | $-3.9M | ||
| Q1 24 | $-14.4M | $5.1M |
| Q4 25 | — | $-2.1M | ||
| Q3 25 | — | $-61.2K | ||
| Q2 25 | — | $5.4M | ||
| Q1 25 | — | $-362.7K | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $814.2K | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | — | $3.6M |
| Q4 25 | — | -72.5% | ||
| Q3 25 | — | -1.1% | ||
| Q2 25 | — | 77.6% | ||
| Q1 25 | — | -5.1% | ||
| Q4 24 | — | -19.5% | ||
| Q3 24 | — | 10.9% | ||
| Q2 24 | — | -64.7% | ||
| Q1 24 | — | 48.9% |
| Q4 25 | — | 21.2% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | 0.0% | 2.8% | ||
| Q3 24 | 0.0% | 1.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 21.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 34.12× | ||
| Q1 25 | — | 0.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.54× | ||
| Q2 24 | — | -3.22× | ||
| Q1 24 | — | 10.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
